series-a
Stage
1
Investors
About
Serpin Pharma develops targeted peptide therapeutics that modulate the immune response to reduce inflammation and restore immune balance, focusing on conditions such as acute myocardial infarction.
Explore Serpin Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.